Alberto Órfão

58.6k total citations · 1 hit paper
463 papers, 16.1k citations indexed

About

Alberto Órfão is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Alberto Órfão has authored 463 papers receiving a total of 16.1k indexed citations (citations by other indexed papers that have themselves been cited), including 198 papers in Immunology, 135 papers in Hematology and 116 papers in Molecular Biology. Recurrent topics in Alberto Órfão's work include Chronic Lymphocytic Leukemia Research (69 papers), Lymphoma Diagnosis and Treatment (64 papers) and Acute Myeloid Leukemia Research (62 papers). Alberto Órfão is often cited by papers focused on Chronic Lymphocytic Leukemia Research (69 papers), Lymphoma Diagnosis and Treatment (64 papers) and Acute Myeloid Leukemia Research (62 papers). Alberto Órfão collaborates with scholars based in Spain, Netherlands and Portugal. Alberto Órfão's co-authors include Jesús F. San Miguel, Júlia Almeida, Jacques J. M. van Dongen, Luís Escribano, Andrés C. García‐Montero, Marcos González, María‐Belén Vídriales, Laura Sánchez‐Muñoz, María Dolores Tabernero and Cristina Teodósio and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Alberto Órfão

451 papers receiving 15.8k citations

Hit Papers

Minimal residual disease ... 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies
    2015 332 citations Jacques J. M. van Dongen, Vincent H. J. van der Velden et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alberto Órfão Spain 66 5.8k 5.4k 4.5k 3.4k 3.1k 463 16.1k
Lothar Kanz Germany 83 6.3k 1.1× 6.3k 1.2× 5.8k 1.3× 3.4k 1.0× 6.6k 2.1× 579 22.1k
Christian Peschel Germany 69 4.9k 0.8× 3.1k 0.6× 5.8k 1.3× 2.7k 0.8× 5.2k 1.7× 345 16.8k
Lee M. Nadler United States 79 14.5k 2.5× 3.6k 0.7× 5.1k 1.1× 2.7k 0.8× 6.5k 2.1× 268 24.6k
G Hale United Kingdom 67 6.7k 1.2× 4.7k 0.9× 2.8k 0.6× 2.5k 0.8× 2.8k 0.9× 267 15.5k
Franco Dammacco Italy 72 3.9k 0.7× 5.0k 0.9× 5.9k 1.3× 2.5k 0.7× 4.3k 1.4× 385 17.0k
Koichi Akashi Japan 83 12.0k 2.1× 10.0k 1.9× 11.6k 2.6× 3.2k 0.9× 6.2k 2.0× 680 29.8k
John F. DiPersio United States 70 5.1k 0.9× 12.0k 2.2× 6.4k 1.4× 3.2k 0.9× 5.9k 1.9× 596 20.8k
Herman Waldmann United Kingdom 105 22.3k 3.8× 5.8k 1.1× 6.9k 1.5× 2.9k 0.9× 5.4k 1.7× 539 36.5k
David J. Rawlings United States 67 9.5k 1.6× 1.5k 0.3× 5.2k 1.1× 2.7k 0.8× 2.4k 0.8× 260 16.3k
David A. Williams United States 74 5.5k 0.9× 3.6k 0.7× 11.0k 2.4× 3.0k 0.9× 3.6k 1.2× 338 21.2k

Countries citing papers authored by Alberto Órfão

Since Specialization
Citations

This map shows the geographic impact of Alberto Órfão's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Órfão with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Órfão more than expected).

Fields of papers citing papers by Alberto Órfão

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Órfão. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Órfão. The network helps show where Alberto Órfão may publish in the future.

Co-authorship network of co-authors of Alberto Órfão

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Órfão. A scholar is included among the top collaborators of Alberto Órfão based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Órfão. Alberto Órfão is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiodin, Giorgia, et al.. (2025). Identification, assembly and characterization of tumor immunoglobulin transcripts from RNA sequencing data using IgSeqR. Nature Protocols. 20(12). 3509–3527. 1 indexed citations
2.
3.
González‐de‐Olano, David, Javier I. Muñoz‐González, Laura Sánchez‐Muñoz, et al.. (2023). Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals. Allergy. 79(3). 711–723. 21 indexed citations
4.
Rama, Tiago Azenha, Ana Henriques, Laura Sánchez‐Muñoz, et al.. (2022). Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell Clonality. The Journal of Allergy and Clinical Immunology In Practice. 11(3). 908–919.e4. 11 indexed citations
5.
6.
Matarraz, Sergio, Stefan Nierkens, Paula Fernández, et al.. (2022). Quality Assessment of a Large Multi-Center Flow Cytometric Dataset of Acute Myeloid Leukemia Patients—A EuroFlow Study. Cancers. 14(8). 2011–2011. 4 indexed citations
7.
Tensen, Cornelis P., Alita J. van der Sluijs‐Gelling, Cristina Teodósio, et al.. (2021). Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndrome. Blood. 138(24). 2539–2554. 29 indexed citations
8.
García‐Sancha, Natalia, Roberto Corchado‐Cobos, Concepción Román‐Curto, et al.. (2021). Overcoming Resistance to Immunotherapy in Advanced Cutaneous Squamous Cell Carcinoma. Cancers. 13(20). 5134–5134. 12 indexed citations
9.
Jara‐Acevedo, María, Carolina Caldas, Paloma Bárcena, et al.. (2020). STAT3 and STAT5B Mutations in T/NK-Cell Chronic Lymphoproliferative Disorders of Large Granular Lymphocytes (LGL): Association with Disease Features. Cancers. 12(12). 3508–3508. 36 indexed citations
10.
Flores‐Montero, Juan, Georgiana Grigore, Rafael Fluxá, et al.. (2019). EuroFlow Lymphoid Screening Tube (LST) data base for automated identification of blood lymphocyte subsets. Journal of Immunological Methods. 475. 112662–112662. 26 indexed citations
11.
Velden, Vincent H. J. van der, Juan Flores‐Montero, Martín Pérez‐Andrés, et al.. (2017). Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples. Journal of Immunological Methods. 475. 112287–112287. 25 indexed citations
12.
Villegas, Ana, Beatriz Arrizabalaga, Santiago Bonanad, et al.. (2016). Consenso español para el diagnóstico y tratamiento de la hemoglobinuria paroxística nocturna. Medicina Clínica. 146(6). 278.e1–278.e7. 12 indexed citations
13.
Paiva, Bruno, Teresa Paíno, Mercedes Garayoa, et al.. (2013). Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile. Blood. 122(22). 3591–3598. 115 indexed citations
14.
Henriques, Ana, Arancha Rodríguez‐Caballero, Wendy G. Nieto, et al.. (2013). Combined Patterns of IGHV Repertoire and Cytogenetic/Molecular Alterations in Monoclonal B Lymphocytosis versus Chronic Lymphocytic Leukemia. PLoS ONE. 8(7). e67751–e67751. 49 indexed citations
15.
González‐González, María, Sergio Matarraz, María Jara‐Acevedo, et al.. (2011). Nanotechniques in proteomics: Protein microarrays and novel detection platforms. European Journal of Pharmaceutical Sciences. 45(4). 499–506. 57 indexed citations
16.
Órfão, Alberto, Andrés C. García‐Montero, Laura Sánchez‐Muñoz, & Luís Escribano. (2007). Recent advances in the understanding of mastocytosis: the role of KIT mutations*. British Journal of Haematology. 138(1). 12–30. 163 indexed citations
17.
Paiva, Artur, et al.. (2004). Immunophenotypic and Functional Characterization of Cord Blood Dendritic Cells. Stem Cells and Development. 13(1). 63–70. 27 indexed citations
18.
Espinosa, Ana, María Dolores Tabernero, María Carmen García-Macías, et al.. (2003). Her-2/neuGene Amplification in Familial vs Sporadic Breast Cancer. American Journal of Clinical Pathology. 120(6). 917–927. 8 indexed citations
19.
Manso, M. A., et al.. (1997). Long-term blockade of cholecystokinin (CCK): effects of L 364,718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion.. PubMed. 15(3). 314–22. 9 indexed citations
20.
Macedo, Antônio Vaz de, Alberto Órfão, Juana Ciudad, et al.. (1995). Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease.. PubMed. 9(11). 1896–901. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lothar Kanz Breakdown of academic impact, for papers by Christian Peschel Breakdown of academic impact, for papers by Lee M. Nadler Breakdown of academic impact, for papers by G Hale Breakdown of academic impact, for papers by Franco Dammacco Breakdown of academic impact, for papers by Koichi Akashi Breakdown of academic impact, for papers by John F. DiPersio Breakdown of academic impact, for papers by Herman Waldmann Breakdown of academic impact, for papers by David J. Rawlings Breakdown of academic impact, for papers by David A. Williams
Rankless by CCL
2026